The emergence of the probiotic GLP-1 supplement category represents market response to this accessibility gap
A meta-analysis evaluating GLP-1 RAs, including exenatide and liraglutide, found these agents more effective in reducing both SBP and DBP compared to insulin and other oral antidiabetics, providing additional cardiovascular benefits [86]
Manufacturers must strike a delicate balance between access, value perception, and sustaining profitability in the context of reimbursement constraints
It has been studied for its role in modulating physiological processes such as sleep regulation, stress response, and metabolic functions in research subjects
Patient Selection : Suitable for patients with obesity or overweight with related comorbidities, especially those who have not responded adequately to other weight loss interventions